开拓药业-B股东将股票由富途证券国际香港转入中银国际证券转仓市值1.24亿港元_老虎社区_美港股上老虎

开拓药业-B股东将股票由富途证券国际香港转入中银国际证券转仓市值1.24亿港元

智通财经2025-08-01

智通财经APP获悉，香港联交所最新资料显示，7月31日，开拓药业-B(09939)股东将股票由富途证券国际香港转入中银国际证券，转仓市值1.24亿港元，占比11.04%。开拓药业发布公告，2025年8月1日(交易时段前)，公司、童友之博士及卖方(即KT International Investment Limited，由童博士全资拥有)与配售代理(即中银国际)订立该协议，据此，(i)卖方同意出售而...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

暂无评论

热议股票

7x24

全部

{"i18n":{"language":"zh_CN"},"data":{"share":"https://www.laohu8.com/m/news/2556485214?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-08-01 08:19","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2556485214","market":"sh","top_or_hot":-1,"title":"开拓药业-B股东将股票由富途证券国际香港转入中银国际证券 转仓市值1.24亿港元","media":"智通财经","content":"<div>\n<p>智通财经APP获悉，香港联交所最新资料显示，7月31日，开拓药业-B(09939)股东将股票由富途证券国际香港转入中银国际证券，转仓市值1.24亿港元，占比11.04%。开拓药业发布公告，2025年8月1日(交易时段前)，公司、童友之博士及卖方(即KT International Investment Limited，由童博士全资拥有)与配售代理(即中银国际)订立该协议，据此，(i)卖方同意出售而...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080108233494c772aa&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>开拓药业-B股东将股票由富途证券国际香港转入中银国际证券 转仓市值1.24亿港元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n开拓药业-B股东将股票由富途证券国际香港转入中银国际证券 转仓市值1.24亿港元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-08-01 08:19 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080108233494c772aa&s=b><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP获悉，香港联交所最新资料显示，7月31日，开拓药业-B(09939)股东将股票由富途证券国际香港转入中银国际证券，转仓市值1.24亿港元，占比11.04%。开拓药业发布公告，2025年8月1日(交易时段前)，公司、童友之博士及卖方(即KT International Investment Limited，由童博士全资拥有)与配售代理(即中银国际)订立该协议，据此，(i)卖方同意出售而...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080108233494c772aa&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0276","symbol_name":"资本市场","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080108233494c772aa&s=b","article_id":"2556485214","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080108233494c772aa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2556485214","pubTimestamp":1754007552,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"智通财经APP获悉，香港联交所最新资料显示，7月31日，开拓药业-B股东将股票由富途证券国际香港转入中银国际证券，转仓市值1.24亿港元，占比11.04%。董事认为，配售事项及认购事项亦将为公司提供进一步集资的机会，同时扩大公司的股东基础及资本基础。经扣除相关费用及开支后，认购事项的所得款项净额估计约为4034万港元。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"161027":"证券","601696":"中银证券","BK0276":"资本市场","FUTU":"富途控股"},"translate_title":"Kintor Pharmaceuticals-B shareholder transferred shares from Futu Securities International Hong Kong to BOCI Securities with a market value of HK $124 million","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"161027":1,"601696":0.9,"FUTU":0.9},"content_text":"智通财经APP获悉，香港联交所最新资料显示，7月31日，开拓药业-B(09939)股东将股票由富途证券国际香港转入中银国际证券，转仓市值1.24亿港元，占比11.04%。开拓药业发布公告，2025年8月1日(交易时段前)，公司、童友之博士及卖方(即KT International Investment Limited，由童博士全资拥有)与配售代理(即中银国际)订立该协议，据此，(i)卖方同意出售而配售代理同意(作为卖方的代理)尽最大努力促使买方按每股股份2.08港元的价格购买卖方持有的合共2067.3万股股份，相当于公司于本公告日期的已发行股本约4.62%；及(ii)卖方有条件同意作为委托人按认购价(相当于配售价每股股份2.08港元)认购而公司有条件同意发行2067.3万股新股份(即认购股份)。进行配售事项及认购事项旨在补充集团的一般业务及增长策略的长期资金。董事认为，配售事项及认购事项亦将为公司提供进一步集资的机会，同时扩大公司的股东基础及资本基础。经扣除相关费用及开支后，认购事项的所得款项净额估计约为4034万港元。公司拟将认购事项所得款项净额用于集团的一般营运资金及一般业务。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"hasMoreComments":false,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"isCrawlerRequest":true}